When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KRYS - Up 48% in 2023 Is This Biotech Stock a Buy?
Krystal Biotech Inc.
2023-06-03 08:30:00 ET
This year has been a good one for equity markets so far, but even by that standard, some stocks are doing incredibly well.
That's the case with Krystal Biotech (NASDAQ: KRYS) , a mid-cap company that is already up 48% in 2023. As is often the case in this industry, the rare-diseases-focused biopharmaceutical company owes its solid run on the stock market to a recent regulatory approval (more on that below).
But after gaining that much, is Krystal Biotech still worth investing in at current levels? Let's find out.